Thomas J. Montine

50.9k total citations · 1 hit paper
37 papers, 2.9k citations indexed

About

Thomas J. Montine is a scholar working on Physiology, Psychiatry and Mental health and Neurology. According to data from OpenAlex, Thomas J. Montine has authored 37 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Physiology, 10 papers in Psychiatry and Mental health and 8 papers in Neurology. Recurrent topics in Thomas J. Montine's work include Alzheimer's disease research and treatments (19 papers), Dementia and Cognitive Impairment Research (10 papers) and Antioxidant Activity and Oxidative Stress (6 papers). Thomas J. Montine is often cited by papers focused on Alzheimer's disease research and treatments (19 papers), Dementia and Cognitive Impairment Research (10 papers) and Antioxidant Activity and Oxidative Stress (6 papers). Thomas J. Montine collaborates with scholars based in United States, Germany and Switzerland. Thomas J. Montine's co-authors include Gerard D. Schellenberg, James B. Leverenz, Paul K. Crane, Joshua A. Sonnen, Suzanne Craft, John M. Ringman, David A. Bennett, Elaine R. Peskind, Ge Li and Gerald D. Schellenberg and has published in prestigious journals such as JAMA, Journal of Biological Chemistry and Journal of Neuroscience.

In The Last Decade

Thomas J. Montine

36 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Association of Traumatic Brain Injury With Late-Life Neurodegenerative Conditions and Neuropathologic Findings

2016 318 citations Paul K. Crane, Laura E. Gibbons et al. JAMA Neurology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas J. Montine United States	24	1.4k	774	548	537	449	37	2.9k
Laila Abdullah United States	34	1.0k 0.8×	1.1k 1.4×	596 1.1×	471 0.9×	439 1.0×	90	2.9k
Steve Pedrini United States	24	1.6k 1.1×	1.0k 1.3×	471 0.9×	334 0.6×	523 1.2×	43	2.8k
Inês Baldeiras Portugal	26	1.1k 0.8×	835 1.1×	447 0.8×	325 0.6×	393 0.9×	102	2.4k
Annemieke Ruitenberg Netherlands	16	1.6k 1.2×	514 0.7×	923 1.7×	399 0.7×	1.2k 2.6×	26	3.8k
Huadong Zhou China	29	1.9k 1.4×	1.2k 1.6×	561 1.0×	369 0.7×	773 1.7×	120	3.7k
Daniele Tomassoni Italy	33	656 0.5×	790 1.0×	230 0.4×	334 0.6×	647 1.4×	127	3.2k
Heather Wilkins United States	28	1.1k 0.8×	1.4k 1.8×	242 0.4×	274 0.5×	365 0.8×	102	2.9k
Jack C. de la Torre United States	26	1.2k 0.9×	543 0.7×	611 1.1×	305 0.6×	1.0k 2.3×	49	3.1k
Xi‐Chen Zhu China	27	1.2k 0.9×	808 1.0×	407 0.7×	282 0.5×	630 1.4×	48	2.8k
Roberta Borghi Italy	25	2.0k 1.4×	1.2k 1.5×	188 0.3×	426 0.8×	407 0.9×	49	3.2k

Countries citing papers authored by Thomas J. Montine

Since Specialization

Citations

This map shows the geographic impact of Thomas J. Montine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas J. Montine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas J. Montine more than expected).

Fields of papers citing papers by Thomas J. Montine

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas J. Montine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas J. Montine. The network helps show where Thomas J. Montine may publish in the future.

Co-authorship network of co-authors of Thomas J. Montine

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas J. Montine. A scholar is included among the top collaborators of Thomas J. Montine based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas J. Montine. Thomas J. Montine is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cholerton, Brenna, Gary W. Beecham, Christiane Reitz, et al.. (2025). Neuropsychiatric symptom subtypes and dementia‐associated neuropathologic change. Alzheimer s & Dementia. 21(9). e70622–e70622.

Chung, Jaeyoon, Xiaoling Zhang, Mariet Allen, et al.. (2018). Genome-wide pleiotropy analysis of neuropathological traits related to Alzheimer’s disease. Alzheimer s Research & Therapy. 10(1). 22–22. 21 indexed citations

Chibnik, Lori B., Charles C. White, Shubhabrata Mukherjee, et al.. (2017). Susceptibility to neurofibrillary tangles: role of the PTPRD locus and limited pleiotropy with other neuropathologies. Molecular Psychiatry. 23(6). 1521–1529. 45 indexed citations

Shofer, Jane B., Eric C. Petrie, Chang-En Yu, et al.. (2017). Cerebrospinal fluid biomarkers for Alzheimer's and vascular disease vary by age, gender, and APOE genotype in cognitively normal adults. Alzheimer s Research & Therapy. 9(1). 48–48. 35 indexed citations

Baird, Geoffrey S., Thomas J. Montine, Jason J. Chang, Shu‐Ching Hu, & Anthony M. Avellino. (2017). Cerebrospinal Fluid Total Tau is Increased in Normal Pressure Hydrocephalus Patients who Undergo Successful Lumbar Drain Trials. Cureus. 9(5). e1265–e1265. 1 indexed citations

Hanson, Angela J., Pattie S. Green, Thomas J. Montine, et al.. (2013). Effect of Apolipoprotein E Genotype and Diet on Apolipoprotein E Lipidation and Amyloid Peptides. JAMA Neurology. 70(8). 972–972. 81 indexed citations

Ringman, John M., Sally A. Frautschy, Edmond Teng, et al.. (2012). Oral curcumin for Alzheimer's disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study. Alzheimer s Research & Therapy. 4(5). 43–43. 394 indexed citations

Galasko, Douglas, Elaine R. Peskind, Christopher M. Clark, et al.. (2012). Antioxidants for Alzheimer Disease. Archives of Neurology. 69(7). 836–41. 283 indexed citations

Schellenberg, Gerard D. & Thomas J. Montine. (2012). The genetics and neuropathology of Alzheimer’s disease. Acta Neuropathologica. 124(3). 305–323. 171 indexed citations

10.

Mukherjee, Shubhabrata, Sungeun Kim, Laura E. Gibbons, et al.. (2012). Genetic architecture of resilience of executive functioning. Brain Imaging and Behavior. 6(4). 621–633. 20 indexed citations

11.

Green, Pattie S., Thomas J. Montine, Laura D. Baker, et al.. (2011). Diet Intervention and Cerebrospinal Fluid Biomarkers in Amnestic Mild Cognitive Impairment. Archives of Neurology. 68(6). 743–52. 121 indexed citations

12.

Li, Gail, Joshua A. Sonnen, Kathleen S. Montine, & Thomas J. Montine. (2009). Treatment of Latent Stage Alzheimer’s Disease with Statins?. Aging Health. 5(1). 29–32. 1 indexed citations

13.

Martin, Maria del Pilar, Petra D. Cravens, Ryan C. Winger, et al.. (2009). Depletion of B Lymphocytes From Cerebral Perivascular Spaces by Rituximab. Archives of Neurology. 66(8). 1016–20. 69 indexed citations

14.

Reich, Erin E., Thomas J. Montine, & Jason D. Morrow. (2002). Formation of Novel D-Ring and E-Ring Isoprostane-Like Compounds (D4/E4-Neuroprostanes)in Vivo From Docosahexaenoic Acidt. Advances in experimental medicine and biology. 507. 519–524. 4 indexed citations

15.

Murphey, Laine J., Erin Terry, William E. Zackert, et al.. (2002). Formation of Highly Reactive A-ring and J-ring Isoprostane-like Compounds (A4/J4-neuroprostanes) in Vivo from Docosahexaenoic Acid. Journal of Biological Chemistry. 277(39). 36076–36084. 78 indexed citations

16.

Terry, Erin, et al.. (2001). Improved assay for the quantification of the major urinary metabolite of the isoprostane 15-F2t-Isoprostane (8-iso-PGF2α) by a stable isotope dilution mass spectrometric assay. Clinica Chimica Acta. 314(1-2). 93–99. 39 indexed citations

17.

Reich, Erin E., William R. Markesbery, L. Jackson Roberts, et al.. (2001). Quantification of F-Ring and D-/E-Ring Isoprostanes and Neuroprostanes in Alzheimer’s Disease. Advances in experimental medicine and biology. 500. 253–256. 11 indexed citations

18.

Picklo, Matthew J., Sandra J. Olson, William R. Markesbery, & Thomas J. Montine. (2001). Expression and Activities of Aldo-Keto Oxidoreductases in Alzheimer Disease. Journal of Neuropathology & Experimental Neurology. 60(7). 686–695. 81 indexed citations

19.

MORROW, J, Andrew R. Tapper, William E. Zackert, et al.. (1999). Formation of Novel Isoprostane-Like Compounds from Docosahexaenoic Acid. Advances in experimental medicine and biology. 469. 343–347. 11 indexed citations

20.

Montine, Thomas J.. (1992). Massive Pulmonary Embolus and Anabolic Steroid Abuse. JAMA. 267(17). 2328–2328. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact